我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Using a Clinical Formulation to Understand Psychological Distress in People Affected by Huntington`s Disease: A Descriptive, Evidence-Based Model

Ziad Kronfol

Huntington`s disease (HD) is an inherited, life-limiting neurodegenerative condition. People with HD experience changes in cognitive motor and emotional functioning, and can also mainly at later stages exhibit behaviours that professionals and carers might find distressing such as hitting others, throwing objects, swearing or making inappropriate comments. While clinical formulation (an individualised approach used by mental health professionals to describe an individual`s difficulties) is a helpful tool to conceptualise patients` wellbeing, a specific formulation framework has not yet been developed for HD. However, evidence has shown that formulation can help guide clinical interventions and increase consistency of approach across multi-disciplinary teams, refine risk management and improve staff or carers` empathic skills and understanding of complex presentations. As a consequence, this paper proposes a new clinical formulation model for understanding distress among people with HD, based on a bio psychosocial framework [1].